294 related articles for article (PubMed ID: 11308131)
1. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option.
Garbino J; Henry JA; Mentha G; Romand JA
Vet Hum Toxicol; 2001 Apr; 43(2):99-102. PubMed ID: 11308131
[TBL] [Abstract][Full Text] [Related]
2. Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy").
Greene SL; Dargan PI; O'connor N; Jones AL; Kerins M
Am J Emerg Med; 2003 Mar; 21(2):121-4. PubMed ID: 12671812
[TBL] [Abstract][Full Text] [Related]
3. A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response.
Green AR; O'shea E; Colado MI
Eur J Pharmacol; 2004 Oct; 500(1-3):3-13. PubMed ID: 15464016
[TBL] [Abstract][Full Text] [Related]
4. A review of the acute subjective effects of MDMA/ecstasy.
Baylen CA; Rosenberg H
Addiction; 2006 Jul; 101(7):933-47. PubMed ID: 16771886
[TBL] [Abstract][Full Text] [Related]
5. [A case of acute psychotic episode after a single dose of ecstasy].
Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
[TBL] [Abstract][Full Text] [Related]
6. Hyperkalemia in fatal MDMA ('ecstasy') toxicity.
Raviña P; Quiroga JM; Raviña T
Int J Cardiol; 2004 Feb; 93(2-3):307-8. PubMed ID: 14975567
[TBL] [Abstract][Full Text] [Related]
7. The health effects of ecstasy: a literature review.
Gowing LR; Henry-Edwards SM; Irvine RJ; Ali RL
Drug Alcohol Rev; 2002 Mar; 21(1):53-63. PubMed ID: 12189005
[TBL] [Abstract][Full Text] [Related]
8. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment.
Logan BK; Couper FJ
J Forensic Sci; 2001 Nov; 46(6):1426-33. PubMed ID: 11714155
[TBL] [Abstract][Full Text] [Related]
9. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
Karlsen SN; Spigset O; Slørdal L
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):15-24. PubMed ID: 18047478
[TBL] [Abstract][Full Text] [Related]
10. Severe chronic hepatitis secondary to prolonged use of ecstasy and cocaine.
Payancé A; Scotto B; Perarnau JM; de Muret A; Bacq Y
Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):e109-13. PubMed ID: 23910059
[TBL] [Abstract][Full Text] [Related]
11. [Ecstasy-induced fulminant hepatic failure and emergency liver transplantation].
Carrión JA; Escorsell A; Nogué S; Mas A
Med Clin (Barc); 2003 Jun; 121(3):118-9. PubMed ID: 12855141
[No Abstract] [Full Text] [Related]
12. [Auxiliary liver transplantation for acute liver failure after intake of 3,4-methylenedioxymethamphetamine ("Ecstasy")].
Hellinger A; Rauen U; de Groot H; Erhard J
Dtsch Med Wochenschr; 1997 May; 122(22):716-20. PubMed ID: 9213536
[TBL] [Abstract][Full Text] [Related]
13. Ecstasy (MDMA) and oral health.
Brand HS; Dun SN; Nieuw Amerongen AV
Br Dent J; 2008 Jan; 204(2):77-81. PubMed ID: 18268544
[TBL] [Abstract][Full Text] [Related]
14. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney.
Campbell GA; Rosner MH
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1852-60. PubMed ID: 18684895
[TBL] [Abstract][Full Text] [Related]
15. [Acute liver failure following the use of ecstasy (MDMA)].
Lange-Brock N; Berg T; Müller AR; Fliege H; Neuhaus P; Wiedenmann B; Klapp BF; Mönnikes H
Z Gastroenterol; 2002 Aug; 40(8):581-6. PubMed ID: 12297982
[TBL] [Abstract][Full Text] [Related]
16. Ecstasy induced acute hepatic failure. Case reports.
Atayan Y; Çağın YF; Erdoğan MA; Harputluoglu MM; Bilgic Y
Acta Gastroenterol Belg; 2015; 78(1):53-5. PubMed ID: 26118578
[TBL] [Abstract][Full Text] [Related]
17. [Survival after severe ecstasy intoxication].
Dahl MK; Johansen SS; Ramlau J; Jensen KA
Ugeskr Laeger; 2008 Nov; 170(45):3678. PubMed ID: 18986624
[TBL] [Abstract][Full Text] [Related]
18. Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature.
Carvalho M; Carvalho F; Remião F; de Lourdes Pereira M; Pires-das-Neves R; de Lourdes Bastos M
Arch Toxicol; 2002 Apr; 76(3):166-72. PubMed ID: 11967622
[TBL] [Abstract][Full Text] [Related]
19. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
Parrott A
Hum Psychopharmacol; 2003 Mar; 18(2):89-90. PubMed ID: 12590401
[No Abstract] [Full Text] [Related]
20. [Has ecstasy neurotoxic effects in humans?].
Rosenberg R
Ugeskr Laeger; 1999 Dec; 161(50):6941. PubMed ID: 10643384
[No Abstract] [Full Text] [Related]
[Next] [New Search]
